Chen Yulong, Cheng Qingzhou, Zeng Shan, Lv Site
College of Medicine and Health Science, Wuhan Polytechnic University, Wuhan, China.
School of Mathematics and Computer Science, Wuhan Polytechnic University, Wuhan, China.
Front Pharmacol. 2023 Aug 23;14:1190920. doi: 10.3389/fphar.2023.1190920. eCollection 2023.
Migraine is a common neurovascular disorder with typical throbbing and unilateral headaches, causing a considerable healthcare burden on the global economy. This research aims to prepare chitosan-alginate (CS-AL) nanoparticles (NPs) containing Foshousan oil (FSSO) and investigate its potential therapeutic effects on the treatment of migraine. FSSO-loaded CS-AL NPs were prepared by using the single emulsion solvent evaporation method. Lipopolysaccharide (LPS)-stimulated BV-2 cells and nitroglycerin (NTG)-induced migraine mice were further used to explore anti-migraine activities and potential mechanisms of this botanical drug. FSSO-loaded CS-AL NPs (212.1 ± 5.2 nm, 45.1 ± 6.2 mV) had a well-defined spherical shape with prolonged drug release and good storage within 4 weeks. FSSO and FSSO-loaded CS-AL NPs (5, 10, and 15 μg/mL) showed anti-inflammatory activities in LPS-treated BV-2 cells via reducing the levels of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and nitric oxide (NO), but elevating interleukin-10 (IL-10) expressions. Moreover, FSSO-loaded CS-AL NPs (52 and 104 mg/kg) raised pain thresholds against the hot stimulus and decreased acetic acid-induced writhing frequency and foot-licking duration in NTG-induced migraine mice. Compared with the model group, calcitonin gene-related peptide (CGRP) and NO levels were downregulated, but 5-hydroxytryptamine (5-HT) and endothelin (ET) levels were upregulated along with rebalanced ET/NO ratio, and vasomotor dysfunction was alleviated by promoting cerebral blood flow (CBF) in the FSSO-loaded CS-AL NPs (104 mg/kg) group. FSSO-loaded CS-AL NPs could attenuate migraine via inhibiting neuroinflammation in LPS-stimulated BV-2 cells and regulating vasoactive substances in NTG-induced migraine mice. These findings suggest that the FSS formula may be exploited as new phytotherapy for treating migraine.
偏头痛是一种常见的神经血管疾病,伴有典型的搏动性单侧头痛,给全球经济带来了相当大的医疗负担。本研究旨在制备负载佛手散油(FSSO)的壳聚糖-海藻酸盐(CS-AL)纳米颗粒(NPs),并研究其对偏头痛治疗的潜在疗效。采用单乳液溶剂蒸发法制备了负载FSSO的CS-AL NPs。进一步利用脂多糖(LPS)刺激的BV-2细胞和硝酸甘油(NTG)诱导的偏头痛小鼠来探究这种植物药的抗偏头痛活性及其潜在机制。负载FSSO的CS-AL NPs(212.1±5.2 nm,45.1±6.2 mV)呈规则的球形,药物释放时间延长,在4周内具有良好的稳定性。FSSO和负载FSSO的CS-AL NPs(5、10和15μg/mL)在LPS处理的BV-2细胞中通过降低促炎细胞因子如肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和一氧化氮(NO)的水平,同时提高白细胞介素-10(IL-10)的表达,显示出抗炎活性。此外,负载FSSO的CS-AL NPs(52和104 mg/kg)提高了NTG诱导的偏头痛小鼠对热刺激的痛阈,并减少了乙酸诱导的扭体频率和舔足持续时间。与模型组相比,负载FSSO的CS-AL NPs(104 mg/kg)组中降钙素基因相关肽(CGRP)和NO水平下调,但5-羟色胺(5-HT)和内皮素(ET)水平上调,同时ET/NO比值重新平衡,并且通过促进脑血流量(CBF)缓解了血管舒缩功能障碍。负载FSSO的CS-AL NPs可通过抑制LPS刺激的BV-2细胞中的神经炎症和调节NTG诱导的偏头痛小鼠中的血管活性物质来减轻偏头痛。这些发现表明,FSS配方可能被开发为治疗偏头痛的新型植物疗法。